The longer the antithyroid drug is used, the lower the relapse rate in Graves’ disease: a retrospective multicenter cohort study in Korea

被引：0
作者：
So Young Park
Bo Hyun Kim
Mijin Kim
A.Ram Hong
Jun Park
Hyunju Park
Min Sun Choi
Tae Hyuk Kim
Sun Wook Kim
Ho-Cheol Kang
Jae Hoon Chung
机构：
[1] Sungkyunkwan University School of Medicine,Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center
[2] Korea University Ansan Hospital,Division of Endocrinology, Department of Medicine
[3] Pusan National University Hospital,Division of Endocrinology and Metabolism, Department of Internal Medicine, Biomedical Research Institute
[4] Chonnam National University Medical School,Department of Internal Medicine
来源：
Endocrine | 2021年 / 74卷
关键词：
Grave’s disease; Hyperthyroidism; Antithyroid agents; Treatment outcome; Recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：120 / 127
页数：7
相关论文
共 238 条
  • [1] Klein I(1994)Treatment of hyperthyroid disease Ann. Intern. Med. 121 281-288
  • [2] Becker DV(2011)Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves’ disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission Endocr. J. 58 95-100
  • [3] Levey GS(2016)2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis Thyroid 26 1343-1421
  • [4] Konishi T(2018)2018 European Thyroid Association Guideline for the management of Graves’ hyperthyroidism Eur. Thyroid J. 7 167-186
  • [5] Okamoto Y(2005)A systematic review of drug therapy for Graves’ hyperthyroidism Eur. J. Endocrinol. 153 489-498
  • [6] Ueda M(2017)Long-term antithyroid drug treatment: a systematic review and meta-analysis Thyroid 27 1223-1231
  • [7] Fukuda Y(2019)Primary therapy of Graves’ disease and cardiovascular morbidity and mortality: a linked-record cohort study Lancet Diabetes Endocrinol. 7 278-287
  • [8] Harusato I(1992)Antithyroid drug and Graves’ hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission J. Endocrinol. Investig. 15 815-820
  • [9] Tsukamoto Y(1999)Antithyroid drugs and Graves’ disease-prospective randomized assessment of long-term treatment Clin. Endocrinol. 50 127-132
  • [10] Hamada N(2016)Graves’ disease N. Engl. J. Med. 375 1552-1565
12345678910